Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 11, 2025 • 10:01 PM ET

Date/Time Source News Release
07/01/2025 09:50 AM EDT GlobeNewswire Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
07/01/2025 06:05 AM EDT GlobeNewswire atai Life Sciences Announces $50 Million Private Placement Financing
07/01/2025 06:00 AM EDT GlobeNewswire atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
06/15/2025 03:51 PM EDT GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders
06/03/2025 04:49 PM EDT Business Wire ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders
06/03/2025 03:58 PM EDT PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders
06/02/2025 06:00 AM EDT GlobeNewswire atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
05/29/2025 08:30 AM EDT GlobeNewswire atai Life Sciences to Participate in Upcoming Investor Conferences
05/20/2025 07:00 AM EDT GlobeNewswire atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression
05/14/2025 07:00 AM EDT GlobeNewswire atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates
Page